
Thermo Fisher (TMO) | Stock Overview & Key Data
Thermo Fisher Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $672.34 on December 27, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Thermo Fisher TMO | 182.59B Large-cap | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% | -19.04% | -16.91% | 14.10% |
Danaher DHR | 151.04B Large-cap | 5.17% | 9.37% | 10.46% | 3.13% | -8.22% | -21.68% | -18.64% | 14.50% |
Idexx Laboratories IDXX | 52.07B Large-cap | -1.10% | 23.58% | 27.12% | 44.93% | 59.19% | 32.21% | 74.14% | 69.73% |
Agilent Technologies A | 33.86B Large-cap | 4.00% | 5.54% | 6.05% | -11.83% | -10.66% | -14.88% | -13.38% | 21.26% |
Iqvia Holdings IQV | 32.49B Large-cap | 6.24% | 21.19% | 36.07% | -1.07% | -2.07% | -20.26% | -20.05% | 21.27% |
Mettler-Toledo MTD | 27.03B Large-cap | 4.49% | 12.30% | 14.78% | 3.08% | 7.50% | -7.42% | -1.61% | 36.70% |
Ownership & Short Interest
Thermo Fisher Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Thermo Fisher would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TMO's 52-week high and low?
- In the last 52 weeks, Thermo Fisher reached a high of $627.88 (on September 10, 2024) and a low of $385.46 (on June 18, 2025).
- What is the market cap and P/E ratio for TMO?
- Curious about Thermo Fisher's size and valuation? Its market capitalization stands at 182.59B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.98, and the forward P/E (looking ahead) is 20.59.
- Does TMO pay dividends? If so, what's the yield?
- Yes, Thermo Fisher is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.31%, and the company has paid an average of $1.33 per share annually over the past 3 years.
- Who are Thermo Fisher's main competitors or similar companies to consider before investing?
When looking at Thermo Fisher, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Danaher
DHR151.04B Healthcare Diagnostics & Research -21.68% -18.64% Idexx Laboratories
IDXX52.07B Healthcare Diagnostics & Research 32.21% 74.14% Agilent Technologies
A33.86B Healthcare Diagnostics & Research -14.88% -13.38% Iqvia Holdings
IQV32.49B Healthcare Diagnostics & Research -20.26% -20.05% Mettler-Toledo
MTD27.03B Healthcare Diagnostics & Research -7.42% -1.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Thermo Fisher Scientific Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Thermo Fisher's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.42%, the Debt to Equity ratio from the most recent quarter is 69.62, and its Gross Profit Margin stands at 40.61%.
- What is the recent revenue and earnings growth for TMO?
- Looking at Thermo Fisher's growth, its revenue over the trailing twelve months (TTM) was $43B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.00%, and quarterly earnings saw a YoY growth of 4.50%.
- How much of TMO stock is held by insiders and institutions?
- Wondering who owns Thermo Fisher stock? Company insiders (like executives and directors) hold about 0.15% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 92.59%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.